samedan logo

home > ict > summer 2021 > wellbeing in drug delivery marketing
International Clinical Trials

Wellbeing in Drug Delivery Marketing

In drug delivery, marketing teams face relentless pressure to deliver effective campaigns, create stand-out content, and support sales growth at the same time as managing a range of stakeholders (both internal and external), with limited resources. Add the strain of a global pandemic and a gruelling schedule of calls on Zoom and Microsoft Teams, and it’s understandable that personal wellbeing is often relegated to the bottom of the priority list. The challenges around the subject of personal and strategic wellbeing are explored by three experts who share their insights, experiences, and strategies.

Jodie Hill
Managing Partner at Thrive Law

Developing mental resilience and wellness
Jodie began by pointing out that there is a clear business reason for focusing on wellbeing. “Ultimately, when we come out of this – out of lockdown and, moving forward, out of what’s been a really difficult time for so many people – we’ll need to have a resilient team to thrive in whatever the new normal looks like.”

Thrive Law has done a lot of work to address feelings of isolation and maintain a strong sense of togetherness during the pandemic, with particular concern for those who live alone. Jodie said this can be summarised under three main headings...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

About the Authors

Jodie Hill qualified as a Barrister and later cross qualified as a Solicitor in 2013. She is the Founder and Managing Director of Thrive Law. She is the chair of This is Me Yorkshire, a business led campaign focused on opening the conversation around mental health by sharing personal experiences, including her own journey from mental breakdown to breakthrough. Jodie joined the Law Society Employment Law committee in 2020.

With over 30 years’ experience within the pharmaceutical industry Cate Russell is a global leader in ethical sales and marketing. As a certified coach and mentor in the field of emotional intelligence, Cate works with individuals to develop insights into what makes an emotionally intelligent leader.

Chris Hall is Managing Director of Shallcross Partners, a consultancy business focused on creating transformational opportunities for the pharma supply chain. A creative and entrepreneurial leader, Chris has extensive commercial and operational management experience in delivering growth and profitability in pharmaceutical devices and drug delivery systems organisations.

In a career spanning 27 years, Paul Williamson has worked across a range of B2B and B2C sectors in multinational, medium sized, and small integrated marketing agencies. He has led several high-profile brand programmes, and worked extensively with numerous national and international drug delivery and medical device brands in the design, development, and delivery of integrated marketing campaigns. Paul heads up Realia Marketing and is also Chair of the PRCA Marketing Council.
Print this page
Send to a friend
Privacy statement
News and Press Releases

New inline coding solution for pharmaceutical blister packs

How Drop on Demand becomes the standard The new VDP 827 is a standardized inline Drop on Demand (DOD) solution for variable data printing on pharmaceutical blister packs. Many blister machine suppliers are now offering the solution as standard, and retrofits are possible as well. The VDP 827 is accelerating the retirement of embossing technology and offers greater economic benefits than other printing methods.
More info >>

White Papers

Convergence in the Pharmaceutical Market

PCI Pharma Services

Convergence is currently playing a large part in the growth of the pharmaceutical market. The need for convergence is due to many factors including the declining economy and high competition within the sector. There are many convergences within this sector to date; these include the convergence of food based products with medical and health products and the convergence of prescription drugs to over the counter (OTC) products. Although convergence is helping the pharmaceutical industry expand and develop, it also poses some challenges; these include the regulatory outlook and counterfeiting.
More info >>




©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement